|
Code
|
Display
|
|
Ia.1
|
Precursor cell leukaemias |
|
Ia.2
|
Mature B-cell leukaemias |
|
Ia.3
|
Mature T-cell and NK cell leukaemias |
|
Ia.4
|
Lymphoid leukaemia, NOS |
|
IIb.1
|
Precursor cell lymphomas |
|
IIb.2
|
Mature B-cell lymphomas (except Burkitt lymphoma) |
|
IIb.3
|
Mature T-cell and NK-cell lymphomas |
|
IIb.4
|
Non-Hodgkin lymphomas, NOS |
|
IIIa.1
|
Ependymomas |
|
IIIa.2
|
Choroid plexus tumour |
|
IIIc.1
|
Medulloblastomas |
|
IIIc.2
|
PNET |
|
IIIc.3
|
Medulloepithelioma |
|
IIIc.4
|
Atypical teratoid/rhabdoid tumour |
|
IIId.1
|
Oligodendrogliomas |
|
IIId.2
|
Mixed and unspecified gliomas |
|
IIId.3
|
Neuroepithelial glial tumours of uncertain origin |
|
IIIe.1
|
Pituitary adenomas and carcinomas |
|
IIIe.2
|
Tumours of the sellar region (craniopharyngiomas) |
|
IIIe.3
|
Pineal parenchymal tumours |
|
IIIe.4
|
Neuronal and mixed neuronal-glial tumours |
|
IIIe.5
|
Meningiomas |
|
VIa.1
|
Nephroblastoma |
|
VIa.2
|
Rhabdoid renal tumour |
|
VIa.3
|
Kidney sarcomas |
|
VIa.4
|
pPNET of kidney |
|
VIIIc.1
|
Ewing tumour and Askin tumour of bone |
|
VIIIc.2
|
pPNET of bone |
|
VIIId.1
|
Malignant fibrous neoplasms of bone |
|
VIIId.2
|
Malignant chordomas |
|
VIIId.3
|
Odontogenic malignant tumours |
|
VIIId.4
|
Miscellaneous malignant bone tumours |
|
IXb.1
|
Fibroblastic and myofibroblastic tumours |
|
IXb.2
|
Nerve sheath tumours |
|
IXb.3
|
Other fibromatous neoplasms |
|
IXd.1
|
Ewing tumour and Askin tumour of soft tissue |
|
IXd.2
|
pPNET of soft tissue |
|
IXd.3
|
Extrarenal rhabdoid tumour |
|
IXd.4
|
Liposarcomas |
|
IXd.5
|
Fibrohistiocytic tumours |
|
IXd.6
|
Leiomyosarcomas |
|
IXd.7
|
Synovial sarcomas |
|
IXd.8
|
Blood vessel tumours |
|
IXd.9
|
Osseous and chondromatous neoplasms of soft tissue |
|
IXd.10
|
Alveolar soft parts sarcoma |
|
IXd.11
|
Miscellaneous soft tissue sarcomas |
|
Xa.1
|
Intracranial and intraspinal germinomas |
|
Xa.2
|
Intracranial and intraspinal teratomas |
|
Xa.3
|
Intracranial and intraspinal embryonal carcinomas |
|
Xa.4
|
Intracranial and intraspinal yolk sac tumour |
|
Xa.5
|
Intracranial and intraspinal choriocarcinoma |
|
Xa.6
|
Intracranial and intraspinal tumours of mixed forms |
|
Xb.1
|
Malignant germinomas of extracranial and extragonadal sites |
|
Xb.2
|
Malignant teratomas of extracranial and extragonadal sites |
|
Xb.3
|
Embryonal carcinomas of extracranial and extragonadal sites |
|
Xb.4
|
Yolk sac tumour of extracranial and extragonadal sites |
|
Xb.5
|
Choriocarcinomas of extracranial and extragonadal sites |
|
Xb.6
|
Other and unspecified malignant mixed germ cell tumors of extracranial and extragonadal sites |
|
Xc.1
|
Malignant gonadal germinomas |
|
Xc.2
|
Malignant gonadal teratomas |
|
Xc.3
|
Gonadal embryonal carcinomas |
|
Xc.4
|
Gonadal yolk sac tumour |
|
Xc.5
|
Gonadal choriocarcinoma |
|
Xc.6
|
Malignant gonadal tumours of mixed forms |
|
Xc.7
|
Malignant gonadal gonadoblastoma |
|
XIf.1
|
Carcinomas of salivary glands |
|
XIf.2
|
Carcinomas of colon and rectum |
|
XIf.3
|
Carcinomas of appendix |
|
XIf.4
|
Carcinomas of lung |
|
XIf.5
|
Carcinomas of thymus |
|
XIf.6
|
Carcinomas of breast |
|
XIf.7
|
Carcinomas of cervix uteri |
|
XIf.8
|
Carcinomas of bladder |
|
XIf.9
|
Carcinomas of eye |
|
XIf.10
|
Carcinomas of other specified sites |
|
XIf.11
|
Carcinomas of unspecified site |
|
XIIa.1
|
Gastrointestinal stromal tumour |
|
XIIa.2
|
Pancreatoblastoma |
|
XIIa.3
|
Pulmonary blastoma and pleuropulmonary blastoma |
|
XIIa.4
|
Other complex mixed and stromal neoplasms |
|
XIIa.5
|
Mesothelioma |
|
XIIa.6
|
Other specified malignant tumours |